keyword
https://read.qxmd.com/read/35370692/kidney-microrna-expression-pattern-in-type-2-diabetic-nephropathy-in-btbr-ob-ob-mice
#1
JOURNAL ARTICLE
Lucas Opazo-Ríos, Antonio Tejera-Muñoz, Manuel Soto Catalan, Vanessa Marchant, Carolina Lavoz, Sebastián Mas Fontao, Juan Antonio Moreno, Marta Fierro Fernandez, Ricardo Ramos, Beatriz Suarez-Alvarez, Carlos López-Larrea, Marta Ruiz-Ortega, Jesús Egido, Raúl R Rodrigues-Díez
Diabetic nephropathy (DN) is the main leading cause of chronic kidney disease worldwide. Although remarkable therapeutic advances have been made during the last few years, there still exists a high residual risk of disease progression to end-stage renal failure. To further understand the pathogenesis of tissue injury in this disease, by means of the Next-Generation Sequencing, we have studied the microRNA (miRNA) differential expression pattern in kidneys of Black and Tan Brachyury (BTBR) ob/ob (leptin deficiency mutation) mouse...
2022: Frontiers in Pharmacology
https://read.qxmd.com/read/29429256/-prevalence-and-risk-factors-of-diabetic-retinopathy-in-hospital-patients
#2
JOURNAL ARTICLE
Y Zhang, M Niu, Y Li, J Wang, B Qu, C X Zheng, P Huang, W H Yu
Objective: To analyze the prevalence and risk factors of diabetic retinopathy (DR) in ophthalmic patients. Methods: A cross-sectional study was performed. Diabetic patients who were admitted to Department of Ophthalmology, Traditional Chinese Medicine Hospital of Muping between October 2012 and June 2013 were included. General information and medical history were obtained from each subject by questionaires. Laboratory and detailed ophthalmic examinations were performed during the study. DR was diagnosed and graded by mydriatic fundus photography...
February 6, 2018: Zhonghua Yi Xue za Zhi [Chinese medical journal]
https://read.qxmd.com/read/28682032/-diabetic-nephropathy-and-cardiovascular-risk
#3
REVIEW
Luigi Rossi, Loreto Gesualdo
The curious case of the Diabetic Nephropathy (DN) : paraphrasing the name of a famous movie is certainly an unusual way to deal with a medical-scientific issue, but it could be extremely functional. Benjamin Button, with his backward life, breaks the unquestionable certainty of human life progressing through fixed steps. Similarly, the knowledge of DN seems go backwards; therefore, although it is a pathology which clinicians are usually sure, maybe too sure, they know every aspect of, the clinical nephrologist managing a diabetic patient often finds himself/herself far from his/her old certainties and proper answers...
March 2017: Giornale Italiano di Nefrologia: Organo Ufficiale Della Società Italiana di Nefrologia
https://read.qxmd.com/read/25331664/-myopathy-and-rhabdomyolysis-after-treatment-with-simvastatin-amlodipine-and-roxithromycin
#4
Sara Lyngby Skovbølling, Mette Lindelof
This is a case report of a 71-year-old male with known diabetes, hypertension and diabetic nephropaty who over the course of one year developed an unrecognized myopathy due to concomitant treatment with high-dose simvastatin and amlodipin. Due to rhabdomyolysis he was after seven days of treatment with roxithromycin admitted to hospital with loss of the ability to walk. We wish to raise awareness of the potentially severe side effects of simvastatin and to emphasize that these can be limited by increased attention to patients with risk factors and to interactions with other drugs...
October 6, 2014: Ugeskrift for Laeger
https://read.qxmd.com/read/24013146/-neutrophils-expression-of-adhesion-molecules-in-diabetic-nephropaty-patients
#5
COMPARATIVE STUDY
T D Shcherban'
CD11b and CD54 expression on neutrophils in patients with diabetic nephropathy (DN), arterial hypertension patients and healthy donors were examined. Development of DN associates with an increase of the number of CD11b and CD54 positive cells and violation of cellular co-operation. In the conditions of diabetic microenvironment expression of adhesion molecules rises substantially, what may characterized the mechanism of connection between hyperglycemia and vascular and tissues injury at DN. Authentication of morphological and biochemical markers of intercellular co-operation must in a prospect assist the deeper understanding of pathogenic mechanisms of DN...
July 2013: Georgian Medical News
https://read.qxmd.com/read/23928803/perindopril-treatment-in-streptozotocin-induced-diabetic-nephropaty
#6
JOURNAL ARTICLE
J Trojacanec, D Zafirov, N Labacevski, K Jakjovski, P Zdravkovski, P Trojacanec, G Petrusevska
Diabetic nephropathy (DN) is one of the most common causes of terminal stadium damage to the kidneys. The angiotensin-converting enzyme (ACE) represents a significant risk factor for the progression of DN. ACE inhibitors are medications of particular interest knowing the role of angiotensin II in the development of DN. This study aimed to examine the effects of ACE inhibitor treatment perindopril (PER), administered to rats with streptozotocin (STZ) induced DN, that developed albuminuria, renal hypertrophy and mild glomerulussclerosis...
2013: Prilozi (Makedonska Akademija Na Naukite i Umetnostite. Oddelenie za Medicinski Nauki)
https://read.qxmd.com/read/23029130/involvement-of-the-tubular-clc-type-exchanger-clc-5-in-glomeruli-of-human-proteinuric-nephropathies
#7
JOURNAL ARTICLE
Monica Ceol, Emilia Tiralongo, Hans J Baelde, Daniela Vianello, Giovanni Betto, Annunziata Marangelli, Luciana Bonfante, Marialuisa Valente, Mila Della Barbera, Angela D'Angelo, Franca Anglani, Dorella Del Prete
UNLABELLED: Glomerular protein handling mechanisms have received much attention in studies of nephrotic syndrome. Histopathological findings in renal biopsies from severely proteinuric patients support the likelihood of protein endocytosis by podocytes. ClC-5 is involved in the endocytosis of albumin in the proximal tubule. AIM: To investigate whether ClC-5 is expressed in the glomerular compartment and whether it has a role in proteinuric nephropathies. ClC-5 expression was studied using Real-time PCR in manually- and laser-microdissected biopsies from patients with type 2 diabetes (n 37) and IgA nephropathy (n 10); in biopsies of membranous glomerulopathy (MG) (n 14) immunohistochemistry for ClC-5 (with morphometric analysis) and for WT1 was done...
2012: PloS One
https://read.qxmd.com/read/21991851/-role-of-lipoic-acid-in-health-and-disease
#8
REVIEW
Halina Huk-Kolega, Beata Skibska, Paulina Kleniewska, Aleksandra Piechota, Łukasz Michalski, Anna Goraca
Oxidative stress disturbs organism's homeostasis and leads to excessive reactive oxygen species (ROS) production. Researchers are still focused on antioxidants that help to reduce oxidative stress level and are helpful in treatment of diseases were ROS overproduction is observed. Among those antioxidants is lipoic acid (LA). When applied systemically LA accumulates in tissues and is converted to dihyrolipoic acid (DHLA) by lipoamide dehydrogenase. Both LA and DHLA are biologically active. LA scavenges hydroxyl radical, subchloric acid and singlet oxygen...
September 2011: Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego
https://read.qxmd.com/read/18853664/-clinical-state-of-a-patient-with-nephrotic-proteinuria-successfully-treated-with-combined-therapy-with-angiotensin-ii-receptor-antagonists-and-angiotensin-ii-converting-enzyme-inhibitors-and-pentoxifylline
#9
JOURNAL ARTICLE
Marcin Renke, Przemysław Rutkowski, Leszek Tylicki, Marcin Zietkiewicz, Wojciech Larczyński, Bolesław Rutkowski
Pharmacological inhibition of the renin-angiotensin-aldosteron system (RAAS) constitutes a cornerstone strategy in the management of patients with chronic nephropaties and proteinuria. Angiotensin converting enzyme inhibitors (ACEI) as well as angiotensin II subtype 1 receptor antagonists (ARA) have been shown to decrease proteinuria, reduce the local renal inflammatory processes and slow the progression of renal insufficiency. Despite recent progress, there is still no optimal therapy which inhibits progression of renal disease...
2008: Przegla̧d Lekarski
https://read.qxmd.com/read/17684966/-ischemic-disease-of-the-kidneys-and-combined-chronic-nephropaties-clinical-and-prognostic-features
#10
JOURNAL ARTICLE
V V Fomin, S V Moiseev, M Iu Shevtsov, I M Kutyrina, E M Shilov, N L Kozlovskaia, A Iu Zaĭtsev, I M Balkarov, O I Taronishvili
AIM: To characterize clinical features and course of ischemic renal disease (IRD) combined with other chronic nephropathies. MATERIAL AND METHODS: We examined 102 patients with IRD treated in the E. M. Tareev clinic of the I. M. Sechenov Moscow Medical Academy in 2001-2006. We made a general clinical examination, clinical and biochemical blood tests. Glomerular filtration rate (GFR) was calculated according to Cockroft-Gault formula. Arterial hypertension was assessed according to ESH...
2007: Terapevticheskiĭ Arkhiv
https://read.qxmd.com/read/16231507/-tesio-catheters-for-long-term-hemodialysis-our-experience-in-a-comarcal-hospital
#11
COMPARATIVE STUDY
R Alvarez Navascués, L Quiñones, J Guerediaga
INTRODUCTION: Good vascular access remains the cornerstone of effective hemodialysis treatment. The Tesio catheters has been proposed to be a reliable source of vascular access for the dialysis patients. SUBJECTS AND METHODS: We examined all Tesio catheters inserted over a 3-year period in our hospital. We obtained age, sex, dialysis duration, original nephropaty, vascular access history, complications, dialysis parameters, catheter function duration, confort level for patients and nurses, and death in all our cases...
2005: Nefrología: Publicación Oficial de la Sociedad Española Nefrologia
https://read.qxmd.com/read/16053016/-octreotide-in-the-treatment-of-angiodysplasia-in-patients-with-advanced-chronic-renal-failure
#12
JOURNAL ARTICLE
M Rivera, J Lucero, A Guerrero, J L Márquez, R Montes, M Suñer, A Ruiz, M A Valdivia, J Mateos
Angiodysplasia is an important cause of gastrointestinal bleeding in patients with chronic renal failure. Octreotide, a long-acting synthetic somatostatin analogue that reduces splachnic blood flow have been used to treat esophageal varicose hemorrhage, but its efficacy for bleeding vascular ecstasies is awaiting support. We present three patients with chronic renal failure (two with diabetic nephropaty and the third with mesangiocapilar glomerulonephritis and hepatic cirrosis), seric creatinine 3-4,5 mg/dl, and recurrent gastrointestinal bleeding due to diffuse angiodysplasia and vascular ecstasies, diagnosed by oral endoscopy, colonoscopy and video capsule...
2005: Nefrología: Publicación Oficial de la Sociedad Española Nefrologia
https://read.qxmd.com/read/16053009/-occult-chronic-kidney-disease-ockd-and-cardiovascular-risk-factors-epidemiologic-study
#13
JOURNAL ARTICLE
A Otero, A Abelleira, P Gayoso
UNLABELLED: Vascular diseases are the first cause of mortality within the occidental world. In Spain, they represent 35.5% within the total of deceases. Vascular diseases, jointly with Diabetic Nephropaty, are the first cause of inclusion of patients in dialysis. In precocious stages of renal disease, and as a consequence of the inflammatory condition generated already exists vascular damage. But its prevention is difficult, because habitually GFR is evaluated by means of plasmatic creatinin rate impeding the suitable detection of renal disease prevailing...
2005: Nefrología: Publicación Oficial de la Sociedad Española Nefrologia
https://read.qxmd.com/read/11820996/-isotopic-renal-study-in-diabetic-nephropathy
#14
JOURNAL ARTICLE
A Benítez Segura, J Martín-Comín, Y Ricart, M T González, M Cortés, M Roca, M C Díaz, M Ramos
UNLABELLED: This study aimed to evaluate the prognostic value of the kidney split function (KSF), the effective renal plasma flow (ERPF) and glomerular filtration rate (GF) in the evolution of diabetic nephropathy. MATERIAL AND METHODS: 125 patients (IDDM:10, NIDDM:115), including 62 men, ages 18-84 years, were studied. In all cases GF (Cr 51 EDTA), ERPF (131I-hippuran), kidney split function (obtained from the 99mTc-MAG3 renogram) and basal serum creatinine (SC) were evaluated at the beginning of the study and patients were clinically followed up for 5 years by SC...
February 2002: Revista Española de Medicina Nuclear
https://read.qxmd.com/read/1124148/-trial-treatment-of-diabetic-retinopathy-by-inhibition-of-pituitary-somatotropin-secretion-with-map
#15
JOURNAL ARTICLE
B Bruni, K Bruni-Bocher, A Della Valle, S Gamba
The recent literature relating to the pathogenesis of diabetic retinopathy, with or without nephropaty, is critically reviewed. Particular attention is given to the Growth Hormone (GH) hypothesis. The various procedures of hypophysectomy are discussed, including the possible ways of suppressing growth hormone production or overproduction by drugs, and expecially by medroxyprogesterone acetate (MAP). Personal results obtained with long-term administration of MAP in deposit form on alternate days in 10 patients with advanced retinopathy are described...
March 21, 1975: Minerva Medica
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.